At the urging of antiabortion advocates and politicians, and based on a flawed and biased report put out by an antiabortion group, the Trump administration announced the launch of a new review of mifepristone—despite 100 peer-reviewed scientific studies proving the safety and efficacy of these medications and safe use by over 7.5 million U.S. women.
On the 25th anniversary of FDA approval of mifepristone, reproductive rights supporters are celebrating the creative, determined and courageous advocates who brought this medication to market.
One organization that played a critical role in bringing mifepristone, known as RU-486, to the United States was the Feminist Majority Foundation (FMF)—today the publisher of Ms.











